SEC Form 3 · accession 0001387985-15-000001
AOXING PHARMACEUTICAL COMPANY, INC. · AXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hui Shao
Director
Period of report
Jan 1, 2015
Accepted (ET)
Feb 3, 2015 · 9:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 142,000 | D |
Table II — derivative securities
No Table II lines on this filing.